The National Institute for Health and Care Excellence (NICE) has approved teplizumab for use on the NHS for people with early-stage type 1 diabetes, marking the start of a new era in how we treat the ...
Dr Elizabeth Robertson, Diabetes UK's Director of Research and Clinical, shares her thoughts following the historic approval of the first type 1 diabetes immunotherapy on the NHS.
What is the main treatment for type 2 diabetes? The main treatments for managing blood sugar levels if you have type 2 diabetes are: ...
Save for later Page saved! You can go back to this later in your Diabetes and Me Close ...
Our analysis has revealed that the number of children receiving treatment for type 2 diabetes in Paediatric Diabetes Units in England and Wales has increased by over 50%. We’re calling on the ...
Treating type 2 diabetes as early as possible helps to reduce risk of future complications, show new findings from a 40-year landmark study that began with funding from Diabetes UK.
There are some very early clues to suggest that coronavirus might be triggering type 1 or type 2 diabetes in some people, or making the condition worse for others. We take a look at the evidence and ...
We take a look at some of the exciting diabetes research developments announced in January 2026, and what the findings could mean for people living with or affected by diabetes.
UPDATE, 22 MAY 2024: We now have new information on the amount of people living with the diabetes, and for more information you can visit our guide on diabetes statistics. The number of people living ...
Low or no-calorie sweeteners continue to receive much publicity, and controversy remains amongst both consumers and healthcare professionals surrounding their use. This is in part explained by the ...
Our new analysis predicts that, without significant government action, up to 5.5m people in the UK could be living with diabetes by 2030.
In some areas of the UK, there are type 2 diabetes remission programmes available through the NHS and health boards. Not every area has a specific type 2 remission programme available, and where there ...